Skip to main content

We’re not only bridging the barrier between mind and body, but we’re also making headlines with our innovative digital therapeutics.

PRESS RELEASES AND ANNOUNCEMENTS

Gut-Brain Connect: How metaMe’s Digital Therapeutic Hopes To Rewire IBS Treatment 

metaMe Health CEO and ex-Takeda executive Tim Rudolphi and partner firm Indegene’s senior vice president Marut Setia discuss with Scrip plans for the… Read more

metaMe Health partners with Indegene to launch Regulora®, an FDA-cleared Prescription Digital Therapeutic for adults with Irritable Bowel Syndrome

Princeton, NJ, and Chicago, IL, United States, March 22, 2022 – Indegene, a technology-led global healthcare solutions provider, and metaMe Health… Read more

metaMe Health Raises $2.2 Million to Bring Its IBS Solution to Market

The launch of Regulora will provide accessible pain relief to the 10-15% of U.S. adults who live with IBS CHICAGO… Read more


COMPANY AND INDUSTRY NEWS

Hear metaMe Health CEO Tim Rudolphi discuss the founding story of our company, the impact of gut-directed hypnotherapy, and the commercialization of PDTs. Listen… Read more

In just a few short years, digital therapeutics (DTx) have become an exciting, incredibly competitive new frontier in healthcare. For those not familiar… Read more

Digital therapeutics (DTx)—software that delivers a clinical mechanism of action, either alone or in combination with other standard-of-care treatments… Read more

STAY CONNECTED TO THE FUTURE OF
PRESCRIPTION DIGITAL THERAPIES

Join our mailing list: